TLSI
TriSalus Life Sciences Inc.
4.30$
+4.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -29.4% | -13.4% | +10.9% | -6.2% | +6.0% | -10.9% | -4.1% | -1.2% | -22.7% | +7.1% | +100.7% | – | |
| – | +284.6% | +8.6% | +17.4% | +8.5% | +22.7% | -4.5% | +16.8% | +80.9% | -35.8% | +12.5% | +105.8% | – | |
| – | – | -112.1% | – | – | – | +242.4% | -186.8% | – | -122.2% | – | -848.0% | – | |
| – | +293.3% | -90.6% | -9.1% | +181.7% | -70.4% | +1,408.0% | -87.7% | +132.3% | -81.0% | +243.9% | +58.2% | – | |
| – | -37.1% | -90.6% | -9.1% | +181.7% | – | – | – | -289.2% | -76.7% | +243.9% | +58.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -13.6% | – | -100.0% | +500.0% | -50.0% | +200.0% | +100.0% | – | |
| – | -99.9% | +7,169.8% | +731.5% | -77.6% | -48.6% | +223.6% | +113.8% | -99.6% | +237.8% | +15,201.4% | -0.1% | – | |
| – | -144.7% | – | – | -141.5% | – | – | +201.5% | -128.2% | – | – | -29.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.